Elranatamab therapy in relapsed refractory multiple myeloma patients with chronic kidney disease: A case series [0.03%]
复发难治性多发性骨髓瘤合并慢性肾脏病患者接受Elranatamab治疗的病例系列研究
Gráinne Marron,Niklesh Warrier,Kelvin Chan et al.
Gráinne Marron et al.
Altered cytoskeletal integrity underlies impaired platelet shape change and defective thrombus formation in ETV6-related thrombocytopenia [0.03%]
ETV6相关性血小板减少症中血小板变形和止血缺陷与细胞骨架完整性受损有关
Ivan P Tesakov,Julia-Jessica D Korobkin,Daria V Fedorova et al.
Ivan P Tesakov et al.
ETV6-related thrombocytopenia (ETV6-RT) is an inherited platelet disorder caused by germline ETV6 variants. Despite recent progress, the mechanisms underlying platelet dysfunction in ETV6-RT remain unclear. We investigated 12 patients from ...
Glofitamab in refractory Burkitt lymphoma-type post-transplant lymphoproliferative disorder [0.03%]
治疗难治性伯基特淋巴瘤型移植后淋巴增生性疾病中的Glofitamab疗法
Ho Pui Jeff Lam,Suzanne Arulogun,N George Mikhaeel et al.
Ho Pui Jeff Lam et al.
Integrating primary care for depression management during transition in sickle cell disease: A pre-post feasibility study [0.03%]
溶血性贫血病患者过渡期间整合初级保健以管理抑郁的可行性研究
Robert M Cronin,Nives Quaye,Kristina Landes et al.
Robert M Cronin et al.
Day-30 IL1RL1, CXCL9 and REG3α are prognostic for survival after mismatched unrelated donor transplantation [0.03%]
不匹配的无关供者移植后IL1RL1、CXCL9和REG3α的预后价值
Trent Wang,Anna C Ferreira,Nasheed M Hossain et al.
Trent Wang et al.
While plasma-derived proteins have emerged as potential biomarkers for prognosis after haematopoietic stem cell transplantation (HSCT), there are insufficient data assessing if established proteins interleukin 1 receptor-like 1 (IL1RL1), ch...
Outcomes of extended reduced-dose apixaban versus full-dose apixaban in cancer-associated venous thromboembolism [0.03%]
延长减量阿哌沙班与全剂量阿哌沙班治疗癌症相关静脉血栓栓塞的结局事件
Jia Yi Tan,Aravinthan Vignarajah,Yong Hao Yeo et al.
Jia Yi Tan et al.
Clinicogenetic characteristics and outcomes of children with NUP98-rearranged acute myeloid leukaemia: A single-centre cohort study of 32 cases [0.03%]
NUP98易位阳性急性髓系白血病患儿的临床遗传特征及预后：32例单中心队列研究
Zhi-Xiao Zhang,Lin Zhang,Ai-Dong Lu et al.
Zhi-Xiao Zhang et al.
NUP98 rearrangements define a high-risk, genetically heterogeneous subtype of paediatric acute myeloid leukaemia (AML), yet comprehensive clinicogenetic and survival data remain limited. This retrospective, single-centre study of 32 paediat...
CD8+ T cells surpass NK cells in granule release assay: Implications for diagnosing primary HLH [0.03%]
细胞毒性试验中T细胞较自然杀伤细胞释放颗粒多对原发性噬血细胞性淋巴组织细胞增生症的诊断意义
Maya Gupta,Shweta Shinde,Aparna Dalvi et al.
Maya Gupta et al.
Impact of CD34+ cell dose on outcomes of related allogeneic PBSCT in adult AML patients [0.03%]
同种异体外周血造血干细胞移植治疗成人急性髓系白血病患者中CD34＋细胞剂量对预后的 影响分析
Yusuke Toda,Tomoyasu Jo,Yasuyuki Arai et al.
Yusuke Toda et al.
CD34+ cell dose is believed to impact the outcomes of allogeneic peripheral blood stem cell transplantation (PBSCT), yet the optimal dose remains unclear. We retrospectively reviewed 2407 adult patients with acute myeloid leukaemia who unde...